Check-Cap Ltd. (CHEK)
0.91
0.03 (3.51%)
At close: Mar 24, 2025, 3:59 PM
0.89
-1.76%
After-hours: Mar 24, 2025, 07:55 PM EDT
3.51% (1D)
| Bid | 0.86 |
| Market Cap | 5.32M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.56M |
| EPS (ttm) | -2.14 |
| PE Ratio (ttm) | -0.43 |
| Forward PE | -0.41 |
| Analyst | n/a |
| Ask | 0.93 |
| Volume | 39,258 |
| Avg. Volume (20D) | 768,696 |
| Open | 0.87 |
| Previous Close | 0.88 |
| Day's Range | 0.80 - 0.93 |
| 52-Week Range | 0.56 - 3.45 |
| Beta | -0.06 |
About CHEK
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Mar 4, 2015
Employees 85
Stock Exchange NASDAQ
Ticker Symbol CHEK
Website https://www.check-cap.com
2 months ago
+17.18%
Check-Cap shares are trading higher after the comp...
Unlock content with
Pro Subscription
